Michael J. Willhauck

1.2k total citations
16 papers, 976 citations indexed

About

Michael J. Willhauck is a scholar working on Genetics, Molecular Biology and Biotechnology. According to data from OpenAlex, Michael J. Willhauck has authored 16 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Biotechnology. Recurrent topics in Michael J. Willhauck's work include Virus-based gene therapy research (8 papers), Cancer Research and Treatments (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Michael J. Willhauck is often cited by papers focused on Virus-based gene therapy research (8 papers), Cancer Research and Treatments (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Michael J. Willhauck collaborates with scholars based in Germany, United States and Italy. Michael J. Willhauck's co-authors include Christine Spitzweg, Burkhard Göke, Christian Zach, Kathrin Klutz, Reingard Senekowitsch–Schmidtke, Ernst Wagner, Nathalie Wunderlich, Hans-Jürgen Stark, Norbert E. Fusenig and Karsten Boehnke and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Michael J. Willhauck

16 papers receiving 967 citations

Peers

Michael J. Willhauck
B Odermatt Switzerland
Stephan Kontos Switzerland
Ako Ishihara United States
R F Tucker United States
Jay George United States
Deepak Bhere United States
Michael J. Willhauck
Citations per year, relative to Michael J. Willhauck Michael J. Willhauck (= 1×) peers Marie Favrot

Countries citing papers authored by Michael J. Willhauck

Since Specialization
Citations

This map shows the geographic impact of Michael J. Willhauck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Willhauck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Willhauck more than expected).

Fields of papers citing papers by Michael J. Willhauck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Willhauck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Willhauck. The network helps show where Michael J. Willhauck may publish in the future.

Co-authorship network of co-authors of Michael J. Willhauck

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Willhauck. A scholar is included among the top collaborators of Michael J. Willhauck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Willhauck. Michael J. Willhauck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Schwenk, Nathalie, Michael J. Willhauck, C Zischek, et al.. (2013). Stromal Targeting of Sodium Iodide Symporter Using Mesenchymal Stem Cells Allows Enhanced Imaging and Therapy of Hepatocellular Carcinoma. Human Gene Therapy. 24(3). 306–316. 42 indexed citations
2.
Vetter, Alexandra, Kathrin Klutz, Michael J. Willhauck, et al.. (2013). Systemic Image-Guided Liver Cancer Radiovirotherapy Using Dendrimer-Coated Adenovirus Encoding the Sodium Iodide Symporter as Theranostic Gene. Journal of Nuclear Medicine. 54(8). 1450–1457. 62 indexed citations
3.
Rosada, Adrian, Ursula Kassner, Anja Vogt, et al.. (2013). Does Regular Lipid Apheresis in Patients With Isolated Elevated Lipoprotein(a) Levels Reduce the Incidence of Cardiovascular Events?. Artificial Organs. 38(2). 135–141. 65 indexed citations
4.
Vetter, Alexandra, Kathrin Klutz, Michael J. Willhauck, et al.. (2013). EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene. Molecular Therapy — Nucleic Acids. 2. e131–e131. 57 indexed citations
5.
Klutz, Kathrin, David Schaffert, Michael J. Willhauck, et al.. (2011). Epidermal Growth Factor Receptor-targeted 131I-therapy of Liver Cancer Following Systemic Delivery of the Sodium Iodide Symporter Gene. Molecular Therapy. 19(4). 676–685. 90 indexed citations
6.
Klutz, Kathrin, Michael J. Willhauck, Nathalie Wunderlich, et al.. (2011). Image-guided, Tumor Stroma-targeted 131I Therapy of Hepatocellular Cancer After Systemic Mesenchymal Stem Cell-mediated NIS Gene Delivery. Molecular Therapy. 19(9). 1704–1713. 72 indexed citations
7.
Klutz, Kathrin, Michael J. Willhauck, Christian Dohmen, et al.. (2011). Image-Guided Tumor-Selective Radioiodine Therapy of Liver Cancer After Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene. Human Gene Therapy. 22(12). 1563–1574. 40 indexed citations
8.
Klutz, Kathrin, Michael J. Willhauck, Nathalie Wunderlich, et al.. (2011). Sodium Iodide Symporter (NIS)-Mediated Radionuclide ( 131 I, 188 Re) Therapy of Liver Cancer After Transcriptionally Targeted Intratumoral in Vivo NIS Gene Delivery. Human Gene Therapy. 22(11). 1403–1412. 44 indexed citations
9.
Willhauck, Michael J., et al.. (2010). Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of 131I by carbamazepine in breast cancer cells. Breast Cancer Research and Treatment. 125(2). 377–386. 13 indexed citations
10.
Klutz, Kathrin, Verena Ruß, Michael J. Willhauck, et al.. (2009). Targeted Radioiodine Therapy of Neuroblastoma Tumors following Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene. Clinical Cancer Research. 15(19). 6079–6086. 59 indexed citations
11.
Willhauck, Michael J., Ingo Wolf, Reingard Senekowitsch–Schmidtke, et al.. (2008). The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 35(7). 1272–1281. 31 indexed citations
12.
Hinkel, Rabea, Chiraz El-Aouni, Jan Horstkotte, et al.. (2008). Thymosin β4 Is an Essential Paracrine Factor of Embryonic Endothelial Progenitor Cell–Mediated Cardioprotection. Circulation. 117(17). 2232–2240. 123 indexed citations
13.
Willhauck, Michael J., Reingard Senekowitsch–Schmidtke, Nathalie Wunderlich, et al.. (2007). Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Research and Treatment. 109(2). 263–272. 26 indexed citations
14.
Willhauck, Michael J., Ingo Wolf, Reingard Senekowitsch–Schmidtke, et al.. (2007). Application of 188Rhenium as an Alternative Radionuclide for Treatment of Prostate Cancer after Tumor-Specific Sodium Iodide Symporter Gene Expression. The Journal of Clinical Endocrinology & Metabolism. 92(11). 4451–4458. 46 indexed citations
15.
Stark, Hans-Jürgen, Karsten Boehnke, Nicolae Mirancea, et al.. (2006). Epidermal Homeostasis in Long-Term Scaffold-Enforced Skin Equivalents. Journal of Investigative Dermatology Symposium Proceedings. 11(1). 93–105. 100 indexed citations
16.
Stark, Hans-Jürgen, Michael J. Willhauck, Nicolae Mirancea, et al.. (2004). Authentic fibroblast matrix in dermal equivalents normalises epidermal histogenesis and dermo-epidermal junction in organotypic co-culture. European Journal of Cell Biology. 83(11-12). 631–645. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026